1H nuclear magnetic resonance study of oxazolidinone binding to bacterial ribosomes

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 3, 2002, Pages 625-629

  Zhou, Casey Chun ^a   Swaney, Steven M ^a   Shinabarger, Dean L ^a   Stockman, Brian J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPEREZOLID; OXAZOLIDINONE DERIVATIVE; PNU 107112; PNU 177553; PNU 184414; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LIGAND;

ANTIBACTERIAL ACTIVITY; ARTICLE; BINDING AFFINITY; CROSS LINKING; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; ENANTIOMER; ESCHERICHIA COLI; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SYNTHESIS INHIBITION; PROTON NUCLEAR MAGNETIC RESONANCE; RIBOSOME; ALGORITHM; CHEMISTRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ALGORITHMS; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; OXAZOLIDINONES; RIBOSOMES;

EID: 0036008047     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.3.625-629.2002     Document Type: Article

References (20)

1. Conformational analysis of the erythromycin analogues azithromycin and clarithromycin in aqueous solution and bound to bacterial ribosomes
2. Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: Correlation between antibiotic activities and bound conformations
3. Conformational analysis of ketolide, conformations of RU 004 in solution and bound to bacterial ribosomes
4. 1H NMR study
5. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections
6. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections
7. 1H transferred NOE study
8. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones
9. In vitro activities of oxazolidinone compounds U-100592 and U-100766 against Staphylococcus aureus and Staphylococcus epidermidis
10. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin
11. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae
12. Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors
13. Recent developments in transferred NOE methods
14. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions
15. Parameters for the preparation of Escherichia coli ribosomes and ribosomal subunits active in tRNA binding
16. Preparation of Escherichia coli ribosomal subunits active in polypeptide synthesis
17. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria
18. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action
19. Allosteric activation of phosphatidylinositol-specific phospholipase C: Specific phospholipid binding anchors the enzyme to the interface
20. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents